Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Why economic indicators matter to investors: indicators help assess health, predict trends, and guide decisions, improving timing and risk management.
27,651 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When markets slump, two crypto giants throw up different signals. This guide breaks down the case for Bitcoin as the ...
SpaceX’s rapid move into index funds signals a shift in how private tech breakthroughs reach everyday investors. This...
Costco's path for 2026-2030 hinges on membership economics, pricing power, and macro demand. This report outlines bas...
Cava Group bets on fresh growth and better margins, even as the market stays wary. This piece breaks down what could ...
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
Stocks declined after the latest U.S. GDP numbers showed solid growth, pushing investors to reassess rate expectation...
NVIDIA hits fresh highs after U.S. regulators approve more H200 chip sales to China, lifting momentum across the AI c...
PepsiCo is set to report Q2 2026 results before the market opens on July 9, 2026, with a fresh price target and impro...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
A spotlight on KNG shows it earns an 8.6% yield by selling covered calls on Dividend Aristocrats, but eight-year retu...
As the S&P 500 earnings season begins, investors focus on underappreciated sectors that could produce big surprises. ...